Clinical Trial Update: TSN2898-201 Safety and Efficacy of TSN2898 in the Treatment of Acne Vulgaris [Phase 2]

View source ↗

Summary

A Phase 2 trial of TSN2898 for acne vulgaris has been withdrawn, with no results reported in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• TSN2898

Snippet

Sponsor: Thesan Pharmaceuticals, Inc. | Conditions: Acne Vulgaris | Phase 2 | Status: WITHDRAWN